Dr. Matthew Mark Schultzel, DO

Dr. Schultzel practices at Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California.

Dr. Schultzel's NPI, 1306123229, was assigned on November 5, 2011. Dr. Schultzel graduated from Touro University California - Vallejo in 2010. Dr. Schultzel's California license number on file is 11955.

Dr. Schultzel's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD, at 28078 Baxter Road, Murrieta, CA 92563.

Dr. Schultzel's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California. Dr. Schultzel is also affiliated with Sharp Memorial Hospital. The medical group on file is United Medical Doctors. Dmand AI also links Dr. Schultzel to 1 more hospital, 3 group practices and clinics, 2 medical groups, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultzel practices, 8 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Schultzel's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Schultzel is board certified in surgery by the AOA Board of Surgery. Dmand AI has Dr. Schultzel's licenses on file in 3 states: California, Texas and New Jersey.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, colonoscopy, colon removal, gallbladder removal, gastrointestinal bleeding and groin hernia surgery among the conditions Dr. Schultzel treats.

CMS data shows 2,144 Medicare services from Dr. Schultzel across 16 procedure codes in 2024, for 444 Medicare patients. Medicare paid $253,091 for them.

CMS counts 444 Medicare patients who saw Dr. Schultzel in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schultzel's median patient age at 58, with 50% women.

In 2022, Dr. Schultzel wrote 24 Medicare Part D claims. They cover 2 drugs, with $1,340 in total drug cost. In 2021, CMS named 120 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schultzel for performance year 2024, reported as part of a group. Dr. Schultzel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schultzel as offering telehealth. CMS counts 42 procedures of hernia repair (minimally invasive) by Dr. Schultzel, more than 98% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Schultzel, published from 2008 to 2022. 2008 was the busiest year, with 2. Dr. Schultzel's most frequent co-authors are Mark Schultzel, MD, Helen Shi Stafford, MD and Tracy M. Downs, MD.

CMS Open Payments shows 529 general payments to Dr. Schultzel from 56 drug and device companies from 2016 to 2025. Education make up the largest share, 41% of the total. Intuitive Surgical, Inc. paid the most, $89,691. It also lists 3 research payments totaling $2,542 from 2016 to 2018.

Dmand AI lists 22 awards for Dr. Schultzel, most recently Fist Osteopathic Surgeon to Use the Intuitive DV5 Robot in 2024. Dr. Schultzel serves on Sharp Healthcare Foundation and Robotic Steering Committee - Sharp Healthcare.

Dr. Schultzel graduated from Touro University California - Vallejo in 2010. Dr. Schultzel is a member of ACS, AOA, ASCRS and SAGES.

Dr. Schultzel is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.